Publications by authors named "Yoshio Itani"

Claim this Profile
P
Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).
Fuminori Ito, Mototsugu Shimokawa, Atsushi Sugiura, Yoshio Itani, Atsushi Arakawa

Arch Gynecol Obstet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of older and younger patients with ovarian cancer: A post hoc study (JGOG3016-A3) of the treatment strength and prognostic outcomes of conventional or dose-dense chemotherapy.
Yoshio Itani, Hitomi Sakai, Tetsutaro Hamano, Mikiko Asai-Sato, Masayuki Futagami

J Obstet Gynaecol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions and practice patterns of cancer survivorship care among Japanese gynecologic oncologists: The JGOG questionnaire survey.
Mikiko Asai-Sato, Nao Suzuki, Hitomi Sakai, Yoshio Itani, Shinya Sato

J Gynecol Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do doctors choose treatment for older gynecological cancer patients? A Japanese Gynecologic Oncology Group survey of gynecologic oncologists.
Makoto Yamamoto, Yoshio Yoshida, Yoshio Itani, Shinya Sato, Masayuki Futagami

Int J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group.
Satoshi Takeuchi, Haruo Kuroboshi, Taisuke Mori, Kimihiko Ito, Eiji Kondo, Yoshio Itani

Chin J Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer.
Fuminori Ito, Atsushi Sugiura, Shinji Toyoda, Yoshio Itani, Kana Iwai

J Obstet Gynaecol Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative cytological findings from the use of the Integran microfibrillar collagen hemostatic matrix in conization.
Shinji Toyoda, Hiroshi Okada, Hideo Tsujino, Yoshinori Takeda, Atsushi Sugiura, Yoshio Itani

Diagn Cytopathol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).
Tomoko Hirakawa, Takeo Minaguchi, Yoshio Itani, Yuka Kasamatsu, Saki Murase

World J Surg Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical adenocarcinoma with stromal micropapillary pattern.
Shinji Toyoda, Tsunekazu Kita, Atsushi Sugiura, Yoshio Itani, Hiroshi Okada

Diagn Cytopathol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330).
Hiroshi Tsubamoto, Ryuji Kawaguchi, Kimihiko Ito, Takaya Shiozaki, Satoshi Takeuchi, Yoshio Itani

Anticancer Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: a Kansai Clinical Oncology Group study (KCOG9812).
Hiroshi Tsubamoto, Yoshio Itani, Kimihiko Ito, Riichiro Kanazawa, Shinji Toyoda

Gynecol Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Munetaka Takekuma, Yasuyuki Hirashima, Kimihiko Ito, Hiroshi Tsubamoto, Tsutomu Tabata, Yoshio Itani

Gynecol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: a Kansai Clinical Oncology Group study (KCOG0015 trial).
Kimihiko Ito, Hiroshi Tsubamoto, Yoshio Itani, Haruo Kuroboshi, Hiroyuki Fujita

Gynecol Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer.
Yoshio Itani, Kenichi Hosokawa, Kimihiko Ito, Satoshi Takeuchi, Tsutomu Tabata

Anticancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary.
Yoshio Itani, Motohiro Kawa, Shinji Toyoda, Keizoh Yamagami, Katsutada Hiraoka

J Obstet Gynaecol Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Phase II study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage I c-IV ovarian cancer--KCOG 989 trial].
Yoshinori Nakata, Toshio Yamada, Ryoji Itoh, Kiyoko Koishi, Katsutada Hiraoka, Yoshio Itani

Gan To Kagaku Ryoho· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ascitic fluid and imprint cytology of mixed germ cell tumor of the ovary.
Yoshio Itani, Motohiro Kawa, Shinji Toyoda, Nobuo Kurai, Keizoh Yamagami

Acta Cytol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis